Terris Tang

Terris’ experience includes advising:

Capital Markets

• The underwriters on the HK$2.7 billion initial public offering of Geekplus, a leading global autonomous mobile robot company, on The Stock Exchange of Hong Kong
• The joint sponsors and underwriters on the HK$1.85 billion initial public offering of Caocao, a leading ride-hailing platform in China, on The Stock Exchange of Hong Kong
• The joint sponsors and underwriters on the HK$1.4 billion initial public offering of Drinda, a leading specialized manufacturer of photovoltaic cells, on The Stock Exchange of Hong Kong
• The underwriters on the HK$333 million initial public offering of Baiwang, a Chinese enterprise digitalization solutions provider, on The Stock Exchange of Hong Kong
• The underwriters on the HK$985 million initial public offering of RoboSense Technology, a global leader in the LiDAR and perception solutions market, on The Stock Exchange of Hong Kong. This transaction was awarded Equity Capital Markets Deal of the Year by China Business Law Journal’s Deals of the Year Awards 2024
• J&T Express, a global logistics service provider, on its HK$3.5 billion initial public offering on The Stock Exchange of Hong Kong; this multi-award winning deal was named Equity Market Deal of the Year – Midsize at the ALB China Law Awards 2024, Best IPO: China-Offshore at the FinanceAsia Achievement Awards 2024, Equity Market Deal of the Year at the ALB SE Asia Law Awards 2024, Equity Deal of the Year at the IFLR Asia-Pacific Awards 2024, and one of the Equity Capital Markets Deals of the Year by China Business Law Journal 2023
• Tianqi Lithium, a leading global lithium producer, on its HK$13.5 billion (US$1.7 billion) H share initial public offering on The Stock Exchange of Hong Kong
• Jinmao Property Services Co. Limited, the leading high-end property management provider in China, on its HK$825 million initial public offering on The Stock Exchange of Hong Kong
• The underwriters in the secondary listing and US$1.07 billion initial public offering of Trip.com, a leading one-stop travel platform globally, on The Stock Exchange of Hong Kong
• The underwriters on the HK$1.824 billion initial public offering of H shares on The Stock Exchange of Hong Kong for Suzhou Basecare Medical, the leading innovative platform of genetic testing solutions for assisted reproduction in China
• Kuaishou Technology, a leading content community and social platform globally, on its US$5.4 billion initial public offering and listing on The Stock Exchange of Hong Kong
• Fulu Holdings, China’s largest third-party virtual service provider, on its US$115 million IPO of shares on The Stock Exchange of Hong Kong
• The underwriters on the HK$2.1 billion initial public offering and listing of Alphamab Oncology, a leading biopharmaceutical company dedicated to global development of innovative biologics for cancer therapy, on The Stock Exchange of Hong Kong
• ESR Cayman Limited on the US$1.5 billion initial public offering and listing on The Stock Exchange of Hong Kong, the third largest IPO in Hong Kong in 2019 and the largest RE IPO in 10 years
• China Risun Group Limited on its HK$1.7 billion initial public offering and listing on The Stock Exchange of Hong Kong; China Risun Group is a world leading independent producer and supplier of coke and coking chemicals
• The Singapore-headquartered data centre provider ST Telemedia Global Data Centres as the shareholder in the secondary listing of GDS Holdings Limited, the leading high performance carrier-neutral data center solution provider in China, on The Stock Exchange of Hong Kong
• Juno Therapeutics (a Bristol Myers Squibb Company), an integrated biopharmaceutical company focusing on developing cellular immunotherapies for the treatment of cancer, as the largest shareholder in the initial public offering of JW (Cayman) Therapeutics Co. Ltd, a leading clinical and pre-clinical stage cell therapy company in China, on The Stock Exchange of Hong Kong
• The underwriters on the HK$5.46 billion initial public offering and listing of Guizhou Bank on The Stock Exchange of Hong Kong
• The underwriters on the HK$2.59 billion initial public offering and listing of Venus MedTech (HangZhou) Inc. on The Stock Exchange of Hong Kong
• Sinochem Hong Kong (Group) and China Jinmao Holdings Group on a placing of existing shares and issuance of new shares, respectively, with a total transaction size of HK$9.49 billion
• The underwriters on the HK$9.1 billion H-share initial public offering of Shenwan Hongyuan Group on The Stock Exchange of Hong Kong
• The joint sponsors and underwriters on Jiangxi Bank’s HK$7.48 billion initial public offering of H Shares on The Stock Exchange of Hong Kong
• China Traditional Chinese Medicine Holdings on the placement of 604.3 million shares to Ping An Life Insurance Company of China for HK$2.68 billion
• Bank of Gansu on its HK$6 billion initial public offering of H shares on The Stock Exchange of Hong Kong, becoming the first listed bank in Northwest China
• China Jinmao Holdings Group on its HK$3.33 billion placing of existing shares and top-up subscription of new shares
• Kunming Dianchi Water Treatment Company, Yunnan’s largest wastewater treatment and reclaimed water supplier, on its HK$1.41 billion initial public offering of H shares on The Stock Exchange of Hong Kong
• Yuk Wing Group Holdings on its initial public offering on the Hong Kong Stock Exchange
• JPMorgan, Goldman Sachs, and UBS as underwriters on the US$748 million initial public offering and listing of HKBN on The Stock Exchange of Hong Kong
• Kinetic Mines and Energy, an integrated coal provider operating in China, on its initial public offering of 930 million shares and listing on The Stock Exchange of Hong Kong, including its international offering (144A/Reg S) of 837 million shares and Hong Kong public offering of 93 million shares
• The underwriters on Bank of China’s initial public offering and listing on The Stock Exchange of Hong Kong*

M&A

• The co-founder and chairman of Kangji Medical as a member of a consortium on a proposed US$1.42 billion privatization of Kangji Medical, a leading medical device platform in China, from the Hong Kong Stock Exchange
• A consortium led by Starwood Capital Group, Sixth Street, and SSW Partners on the US$7.1 billion take-private of ESR Group Limited by way of a scheme of arrangement from the Hong Kong Stock Exchange. This deal represents the largest privatization from the HKEX since 2021
• ESR Group on the sale of its ARA Private Funds business to Sumitomo Mitsui Finance and Leasing Company
• International games and e-sports company Savvy Games Group on its US$265 million investment of a significant stake in China-based leading e-sports company VSPO (formerly VSPN)
• Charoen Pokphand Foods Public Company Limited in its US$900 million privatization of C.P. Pokphand Co. Ltd, a Hong Kong listed company, by way of a scheme of arrangement
• Binance, one of the world’s largest cryptocurrency and blockchain infrastructure providers, in its proposed US$200 million strategic investment in Forbes, the iconic business information brand in the US
• Aspex Management on its Series E investment as lead investor into Klook, an online travel activities and services booking platform company
• Everbright Securities on the purchase of 30% shares of Sun Hung Kai Financial Group Limited held by Sun Hung Kai & Co. Limited
• Huarong Investment Stock Corporation Limited, a Hong Kong listed company, on its privatization by way of scheme of arrangement by Huarong International Financial Holdings Limited
• Bilibili in its strategic investment in Huanxi Media, a company principally engaged in media- and entertainment-related businesses
• China Jinmao as the offeror on the privatization of Jinmao Hotel and Jinmao (China) Hotel Investments and Management Limited — the first-ever privatization of a Hong Kong listed business trust
• Yuk Wing Group Holdings Limited on a mandatory unconditional cash offer for the outstanding shares in the company triggered by the sale of a 51.32% stake by its controlling shareholder
• China Merchants & Great Wall Ocean Strategy & Technology Fund (L.P.) on its HK$512.7 million investment to acquire 51.97% interests in TSC Group Holdings Limited
• HKBN on its approximately US$1.3 billion acquisition of WTT Holding, a Hong Kong-based fixed telecommunication services operator
• China Life Investment Holding on its £795 million acquisition of a majority stake in 10 Upper Bank Street, Canary Wharf, London, which is one of Britain’s biggest office towers, representing the first European property investment by China Life
• China Life Insurance (Overseas) on its acquisition of a minority interest in JD.com, a provider of online shopping services, from an existing shareholder
• PPTV, an online video business in China and its selling shareholders on its sale of 100% of PPTV’s shares held by the existing shareholders valued at US$420 million, to Suning Commerce Group, a domestically listed conglomerate, and Hony Capital, a private equity fund associated with Legend Holding
• Sinochem International (Overseas) on its acquisition of a 40% equity stake in Jiangsu Sinorgchem Technology the world’s leading rubber additive producer and technical developer
• Hong Kong Television Network Limited (formerly known as City Telecom (HK) Limited) (CTI) on its HK$5 billion sale of Hong Kong Broadband Network (HKBN) and IDD businesses to Metropolitan Light Company, a company formed by CVC Funds

*Matter handled prior to joining Latham